Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2006 1
2007 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for advantage methylprednisolone aceponate
Your search for advantan-methylprednisolone-aceponate retrieved no results
Methylprednisolone aceponate in eczema and other inflammatory skin disorders -- a clinical update.
Ruzicka T. Ruzicka T. Int J Clin Pract. 2006 Jan;60(1):85-92. doi: 10.1111/j.1368-5031.2005.00754.x. Int J Clin Pract. 2006. PMID: 16409433 Review.
Methylprednisolone aceponate (MPA) has been shown to provide rapid, reliable and highly effective treatment of eczematous disorders, with an efficacy comparable to that of most reference topical corticosteroids. ...The wide range of formulations (0.1%) of MPA, inclu …
Methylprednisolone aceponate (MPA) has been shown to provide rapid, reliable and highly effective treatment of eczematous diso …
Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis.
Bieber T, Vick K, Fölster-Holst R, Belloni-Fortina A, Städtler G, Worm M, Arcangeli F. Bieber T, et al. Allergy. 2007 Feb;62(2):184-9. doi: 10.1111/j.1398-9995.2006.01269.x. Allergy. 2007. PMID: 17298428 Clinical Trial.
RESULTS: 265 patients were randomized to either MPA (n = 129) or tacrolimus (n = 136) treatment, 257 patients completed the study. Methylprednisolone aceponate 0.1% ointment once daily provided rapid and relevant clinical benefit. Tacrolimus 0.03% ointment twice dai …
RESULTS: 265 patients were randomized to either MPA (n = 129) or tacrolimus (n = 136) treatment, 257 patients completed the study. Methyl …
Comparison of skin atrophy and vasoconstriction due to mometasone furoate, methylprednisolone and hydrocortisone.
Hoffmann K, Auer T, Stücker M, Hoffmann A, Altmeyer P. Hoffmann K, et al. J Eur Acad Dermatol Venereol. 1998 Mar;10(2):137-42. J Eur Acad Dermatol Venereol. 1998. PMID: 9553910 Clinical Trial.
METHODS: In a randomised, double blind intra-individual comparative trial, 10 subjects were treated with various glucocorticoids or drug-free vehicle. The test drugs were mometasone furoate (MF), methylprednisolone aceponate (MP) and hydrocortisone (OH-C). The prepa …
METHODS: In a randomised, double blind intra-individual comparative trial, 10 subjects were treated with various glucocorticoids or drug-fre …